RELUKAST 5mg Price

Overview

Welcome to Dwaey, specifically on RELUKAST 5mg Tablets/Chewable page.
This medicine contains an important and useful components, as it consists of Montelukast (as sodium).
RELUKAST 5mg is available in the market in concentration 5mg/Tablet and in the form of Tablets/Chewable.

HEXAL AG is the producer of RELUKAST 5mg and it is imported from GERMANY, The most popular alternatives of RELUKAST 5mg are listed downward .

Mode Of Action

Montelukast is a selective leukotriene receptor antagonist that blocks the effects of cysteinyl leukotrienes in the airways.

Indication

• Asthma
• Allergic rhinitis

Precaution

Not for the relief of acute bronchospasm. Not to be used as monotherapy for the prevention of exercise-induced bronchospasm. Patients in whom asthma is precipitated by aspirin or other NSAIDs should continue to avoid aspirin and NSAIDs. Do not abruptly substitute for oral or inhaled corticosteroids. Be alert for any signs of Churg-Strauss syndrome. Pregnancy and lactation. Children <6 mth. Lactation: Unknown whether agent is excreted in breast milk, use with caution

Side Effects

• >10% Headache (18.4%; similar to placebo) 1-10% >2% Abdominal pain
• Eczema
• Influenza
• Laryngitis
• Pharyngitis
• Viral infection
• Wheezing
• Dental pain
• Dizziness
• Dyspepsia
• Dental pain (2%)
• Dizziness (2%)
• Dyspepsia (2%)Elevated liver function tests (2%)
• Fever (2%)
• Gastroenteritis (2%)
• Nasal congestion (2%)
• Otitis (2%)
• Rash (2%)
• Urticaria (2%)
• >1% Bronchitis
• Cough
• Sinusitis
• Upper respiratory tract infection <1% Allergic granulomatous angiitis (Churg-Strauss syndrome; rare)
• Cholestatic hepatitis (rare)
• Aggressive behavior
• altered behavior
• suicidal thoughts Potentially Fatal: Anaphylaxis
• Churg-Strauss syndrome.

Contra indication

Hypersensitivity.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.